According to a newly published market research report by 24LifeSciences, global Hepatitis B and C Diagnostics market was valued at USD 3.8 billion in 2024 and is projected to reach USD 5.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period 2025-2031.
Hepatitis B diagnostic tests analyze blood samples for HBV antigens/antibodies (HBsAg, anti-HBc,...
Tiếng Việt 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)